XL Sci-tech, Inc.

Richland, WA 99354
http://www.xlscitech.com
8 Employees

SBIR Award Summary

Total Number of Awards 24
Total Value of Awards $6.57MM
First Award Date 09/30/95
Most Recent Award Date 05/01/16

Key Personnel

Last Name Name Awards Contact
Peng Dr. Y. Benjamin Peng 1 Message
Peng Yongren Benjamin Peng 23

24 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 05/01/16 - 04/30/17

? DESCRIPTION (provided by applicant): Current practice in the USA for inoperable esophageal cancer is a palliative treatment using metal stent for end-stage cancer patients. Outside the USA (especially in far east countries including China and Korea), there have been reported clinical benefits of attaching sealed sources such as prostate...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/01/15 - 08/31/16

DESCRIPTION (provided by applicant): Current radioembolic Y-90 microspheres have been generally recognized as the state-of-the-art for treating primary and metastatic liver tumors. However, the clinical results vary vastly due to the lack of accurate diagnostic imaging for dose and treatment planning, and the lack of image guidance and dose con...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 05/05/15 - 04/30/16

DESCRIPTION (provided by applicant): Current practice in the USA for inoperable esophageal cancer is a palliative treatment using metal stent for end-stage cancer patients. Outside the USA (especially in far east countries including China and Korea), there have been reported clinical benefits of attaching sealed sources such as prostate seed...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/17/14 - 08/31/15

DESCRIPTION (provided by applicant): Current radioembolic Y-90 microspheres have been generally recognized as the state-of-the-art for treating primary and metastatic liver tumors. However, the clinical results vary vastly due to the lack of accurate diagnostic imaging for dose and treatment planning, and the lack of image guidance and dose con...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 06/01/13 - 05/31/14

DESCRIPTION (provided by applicant): Molecularly Engineered Biomaterials for Minimally Invasive Dental Treatment Molecularly-engineered biomaterials are an ideal candidate for minimally invasive dental preparations, caries removal, and other dental treatments, including cleaning in perigingival zone and other general cleaning and whitening. Thr...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 04/04/13 - 12/31/13

DESCRIPTION (provided by applicant): Current practice in the USA for inoperable esophageal cancer is a palliative treatment using metal stent for end-stage cancer patients. Outside the USA (especially in Far East countries including China and Korea), there have been reported clinical benefits of attaching sealed sources such as prostate seeds to...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 08/01/12 - 04/30/13

DESCRIPTION (provided by applicant): Project Summary/Abstract Current radioembolic Y-90 microspheres have been generally recognized as the state-of-the-art for treating primary and metastatic liver tumors. However, the clinical results vary vastly due to the lack of accurate diagnostic imaging for dose and treatment planning, and the lack of...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 09/01/08 - 03/31/09

DESCRIPTION (provided by applicant): Radioisotopes used in targeted therapy are often labeled to targeting biomolecules. Different radioisotope and biomolecule usually require different linkage to bind the radioisotope to the targeting biomolecule. This proposed research is to create modular nano radioisotope sources for improving tumor targetin...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/08 - 08/31/10

DESCRIPTION (provided by applicant): The objective of this Phase I research is to demonstrate the feasibility of creating timed-bioabsorbable Pd-103 seeds for the treatment of prostate tumors. Timed- bioabsorbable seeds have the combined benefits of titanium seeds, high dose rate temporary seeds, external beam radiation and other treatment optio...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/13/07 - 08/31/08

DESCRIPTION (provided by applicant): The objective of this Phase I research is to demonstrate the feasibility of creating timed-bioabsorbable Pd-103 seeds for the treatment of prostate tumors. Timed- bioabsorbable seeds have the combined benefits of titanium seeds, high dose rate temporary seeds, external beam radiation and other treatment optio...

Load More